Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT01961934
Eligibility Criteria:
Inclusion Criteria:
* Patients age 18-70
* Pathologically confirmed World Health Organization (WHO) grade 3 or 4 glioma
* ECOG/Zubrod 0-2
* Prior external beam radiotherapy to 59.4-60 Gray by 1.8-2 Gy fractions
* Post-radiotherapy contrast-enhanced cranial MRI obtained at least 6 weeks after the completion of external beam radiotherapy shows enhancing anomaly (recurrent/progressive tumor versus pseudo-progression versus radionecrosis)
* Patient completed at least a two week course of palliative steroid therapy for this enhancing anomaly
* No prior designated therapy other than steroids for presumed radionecrosis or recurrent tumor
* Patient with no clinical and/or radiological response to steroid therapy
* Patient eligible for stereotactic brain biopsy
* Patient eligible for focal laser therapy
Exclusion Criteria:
* Patients under the age of 18 years
* Claustrophobic patients
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01961934
Study Brief:
Protocol Section:
NCT01961934